HDA UK Media And Political Bulletin – 6 October 2017

Media and Political Bulletin

6 October 2017

Media Summary

‘Any pharmacy’ could receive controlled drug scripts via EPS

Chemist and Druggist, Annabelle Collins, 4 October 2017

Chemist and Druggist reports on the NHS Digital’s recent confirmation that ‘any pharmacy in England’ could receive an electronic prescription for a controlled drug once a pilot launches across five GP practices. This pilot will enable the five practices to prescribe schedule 2 and 3 controlled drugs through the electronic prescription service (EPS), NHS Digital has confirmed to the publication.

NHS Digital has not given a specific launch date for the pilot but the Pharmaceutical Services Negotiating Committee (PSNC) said it anticipated the timings will be announced ‘shortly’.

ABPI Board not to appeal judicial review decision

ABPI, 5 October 2017

Following a decision by the Board of the Association of the British Pharmaceutical Industry, the ABPI have issued a new statement on its application for judicial review versus The National Institute for Health and Care Excellence (NICE).

​​​​​​​​​​This follows yesterday’s confirmation from the Administrative Court that The ABPI’s application for judicial review was turned down.

 

Parliamentary Coverage

 

There is no Parliamentary coverage today.

 

Full Coverage

‘Any pharmacy’ could receive controlled drug scripts via EPS

Chemist and Druggist, Annabelle Collins, 4 October 2017

“Any pharmacy in England” could receive an electronic prescription for a controlled drug once a pilot launches across five GP practices, C+D has learned.

The pilot will enable the five practices to prescribe schedule 2 and 3 controlled drugs through the electronic prescription service (EPS), NHS Digital confirmed to C+D last week (September 29).

It could not give C+D a specific launch date for the pilot but the Pharmaceutical Services Negotiating Committee (PSNC) said it anticipated the timings will be announced “shortly”.

Advance warning

The pharmacies that usually dispense prescriptions from the GP practices involved in the pilot will be informed in advance, NHS Digital said.

However, “all other pharmacies in England will be advised they could receive an EPS prescription that includes controlled drugs”, it added.

NHS Digital told C+D last year that EPS would not be able to handle controlled drugs until 2018, when systems suppliers would have the capability.

“The functionality needed to be available in all pharmacies before we [could] start the pilot,” NHS Digital told C+D last week. “In time all GP practices will include this functionality.”

The GP practices involved in the pilot would be those using the Vision GP IT system in the North West and London, NHS Digital said.

It added that “subject to the pilot being successful”, further GP practices that use ‘Vision’ will begin using EPS to prescribe controlled drugs.

The Department of Health changed the law in 2015 to allow schedule 2 and 3 controlled drugs, including opiates and barbiturates, to be dispensed through EPS.

Since 2005, drugs controlled under schedules 4 and 5 – such as diazepam and preparations containing low strengths of more heavily regulated drugs – have been prescribed electronically.

ABPI Board not to appeal judicial review decision

ABPI, 5 October 2017

Following a decision by the Board of the Association of the British Pharmaceutical Industry (ABPI), the ABPI have issued a new statement on its application for judicial review versus The National Institute for Health and Care Excellence (NICE).

​​​​​​​​​​This follows yesterday’s confirmation from the Administrative Court that The ABPI’s application for judicial review was turned down.

“Following the decision by the Honourable Justice Mrs Elisabeth Laing not to grant the ABPI a judicial review against NICE, the Board of the ABPI has unanimously agreed to accept the decision and will not appeal.

“After months of raising concerns with NICE, NHS England and the Department of Health and offering to work constructively on alternative proposals, the ABPI Board took the exceptional decision in June to apply to the courts to formally challenge new measures introduced by NICE earlier this year for evaluating and funding medicines and other health technologies.

“Our concern has always been that patients should not miss out on medicines which are proven to be both clinically beneficial and cost-effective. Throughout this action the ABPI has maintained positive and constructive dialogue with NICE, the NHS and Government and we are encouraged that the issues are now better understood.

“Working in partnership with industry, Government and the NHS we must now focus on finding real, workable solutions to help NHS patients get fast access to the medicines they need.

“The positive reception by Government to the Life Sciences Industrial Strategy recommendations is a good start and we now look forward to seeing them fully implemented.   This is best achieved through agreeing a strong sector deal that both improves access to new medicines and ensures the UK remains a successful place to research and develop medicines.”

From Factory to Pharmacy

As part of our mission to build awareness, understanding and appreciation of the vital importance of the healthcare distribution sector, we developed an infographic explaining the availability of medicines. It identifies the factors that can impact drug supply, as well as the measures that HDA members undertake day in, day out to help mitigate the risks of patients not receiving their medicines.

See the Infographic

Apply to become a Member

Membership of the HDA guarantees your organisation:

  • Access to leading policy and industry forums of debate and discussion
  • Invitations to a range of networking industry events organised through the year, including an Annual Conference and a Business Day
  • Representation on HDA working parties, including the Members’ Liaison Group
  • A daily Political and Media Bulletin and HDA Newsletters
  • Access to HDA policy documents and all sections of the HDA website
  • Branding and marketing opportunities
Apply Now

Already a Member?